ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
64.49
-0.27 (-0.42%)
Mar 3 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 64.16 - 64.77
52 week 42.19 - 67.50
Open 64.77
Vol / Avg. 470,049.00/1.21M
Mkt cap 9.11B
P/E 26.16
Div/yield 0.28/1.74
EPS 2.47
Shares 140.55M
Beta 0.77
Inst. own 54%
Apr 21, 2015
Q3 2015 ResMed Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 12, 2015
ResMed Inc at Leerink Global Healthcare Conference - Webcast
Jan 22, 2015
Q2 2015 ResMed Inc Earnings Call - Webcast
Jan 22, 2015
Q2 2015 ResMed Inc Earnings Release
Jan 14, 2015
ResMed Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 21.56% 22.20%
Operating margin 25.81% 26.05%
EBITD margin - 31.18%
Return on average assets 15.78% 15.10%
Return on average equity 22.56% 20.50%
Employees 4,100 -
CDP Score - -

Address

9001 Spectrum Center Blvd.
SAN DIEGO, CA 92123
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ResMed Inc. is a holding company for the ResMed Group. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea. The Company offers various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. The Company has manufacturing operations in Australia, Singapore, France, Germany, Malaysia and the United States. Its distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. The Company also offers services to streamline order fulfillment, including VGM, PPM, CpapDropShip and JaySec. The Company´┐Żs subsidiaries include ResMed Hong Kong Limited, ResMed Limited, ResMed India Private Limited and ResMed Taiwan Co., Ltd.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 54
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 42
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Don Darkin President - Sleep-disordered Breathing Strategic Business Unit
Age: 61
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 51
Bio & Compensation  - Reuters
Anne Reiser President, Europe
Age: 53
Bio & Compensation  - Reuters
David Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 66
Bio & Compensation  - Reuters